TLNCW — Talon Capital Corp.
—
Nasdaq ·
Financials ·
Diversified Financial Services ·
CIK 2073340 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 0 | — | -425,687 | 1,985,587 | 261,237,183 | 2,344,991 | 11,095,839 |
| Jun 2026 | 0 | — | -1,009,905 | 1,322,627 | 259,010,121 | 2,399,609 | 10,944,103 |
| Mar 2026 | 0 | — | -342,807 | 1,971,217 | 257,162,549 | 2,653,957 | 10,419,158 |
| Sep 2025 | 0 | — | -233,097 | 383,939 | 252,862,213 | 3,096,635 | 10,368,532 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-749,354
Investing CF
$276,336
Financing CF
—
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-8,362,100
Inventory
—
Receivables
$185,111
ST Investments
—
EBIT TTM
$-1,585,809
Pretax Income TTM
$3,677,783
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 1y)
Revenues vs Net Income (last 1y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | 255,100,876 | 10,328,702 | 244,772,174 | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$259,010,121
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HASI | HA Sustainable Infrastructure Capital, Inc. | $4.86B | $38.01 | — |
| DMII | Drugs Made In America Acquisition II Corp. | $652.61M | $10.24 | — |
| EVAC | EQV Ventures Acquisition Corp. II | $486.85M | $10.37 | — |
| BCSS | Bain Capital GSS Investment Corp. | $480.73M | $10.25 | — |
| CEPF | Cantor Equity Partners IV, Inc. | $473.69M | $10.32 | — |
News headlines (Yahoo Finance, 1h cache)
Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies
2026-04-10 00:00 · Yahoo
Oricell Therapeutics Announces US$70M Initial Closing of Series C Financing, to Accelerate Global Development of Solid Tumor CAR-T Therapies
2026-01-13 01:43 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.